Biofrontera (BFRIW) Non Operating Income (2020 - 2025)
Biofrontera (BFRIW) recorded quarterly Non Operating Income of $632000.0 in Q4 2025, up 2006.67% quarter-over-quarter from $30000.0 in Q3 2025, and up 192.8% on a YoY basis from $215843.5 in Q4 2024.
Biofrontera (BFRIW) Non Operating Income (2020 - 2025) Analysis & Trends
Biofrontera's Non Operating Income history runs 6 years deep, the most recent figure standing at $632000.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 192.8% year-over-year to $632000.0; the TTM figure through Dec 2025 stood at $741000.0 (up 161.7% YoY), while the FY2025 annual figure was $388000.0, up 173.62% from the prior year.
- Non Operating Income was $632000.0 for Q4 2025 at Biofrontera, up from $30000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $8.7 million in Q1 2022 to a low of -$15.1 million in Q4 2022.
- Historically, Non Operating Income has averaged -$605350.0 across 5 years, with a median of $500.0 in 2021.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income jumped 174120.0% in 2022, then plunged 7722.73% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$12.6 million in 2021, then slipped by 19.68% to -$15.1 million in 2022, then jumped by 131.45% to $4.8 million in 2023, then slumped by 114.34% to -$681000.0 in 2024, then jumped by 192.8% to $632000.0 in 2025.
- The last three Non Operating Income figures came in at $632000.0 (Q4 2025), $30000.0 (Q3 2025), and -$264000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Biofrontera | - | - | 14.09 Mn | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | -264,000.00 |
| Mar 31, 2025 | 343,000.00 |
| Dec 31, 2024 | -681,000.00 |
| Sep 30, 2024 | -706,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 180,000.00 |
| Dec 31, 2023 | 4.75 Mn |
| Sep 30, 2023 | -1.72 Mn |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -33,000.00 |
| Dec 31, 2022 | -15.10 Mn |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | 5.36 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | -12.62 Mn |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 70,000.00 |
| Mar 31, 2021 | -5,000.00 |